Solventum Corp reported $1.29B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Align Technology USD 757.43M 20.84M Jun/2026
Baxter International USD 1.14B 251M Jun/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Cencora USD 6.37B 3.37B Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Insulet USD 562.6M 21.8M Jun/2026
Solventum Corp USD 1.29B 189M Jun/2026
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026
Zimmer Biomet Holdings USD 1.36B 149.4M Jun/2026